Mass Spectrometry and SomaScan Concordance Data for Biomarker Panels

Mass spectrometry (MS) – SomaScan (SS) concordance data provides evidence for biomarker panels in a chronic progressive disease study. The 5.5 KB Excel file, authored by Blake Hummer and last updated in March 2026, is licensed for open use under CC-BY-4.0. Platform tags suggest the data relates to a pilot study identifying 68 proteins and staging biomarker profiles.

Use Cases

• Validate SomaScan assay results against mass spectrometry measurements based on the concordance study mentioned.
• Analyze protein biomarker panels for disease staging based on the 'Staging Biomarker Panels' tag.
• Investigate collagen synthesis and degradation pathways in a chronic disease context based on tags like 'Increased Collagen Synthesis' and 'Impaired Degradation Rather'.

Strengths

• File size is 5.5 KB, indicating a focused and likely manageable dataset.
• License is CC-BY-4.0, permitting broad reuse with attribution.
• Last update date is 2026-03-18, suggesting planned future relevance.

Limitations

• Row count and column definitions are unknown, limiting suitability assessment.
• Description metadata is limited; actual data quality requires manual inspection after download.

Provenance

Source

figshare, author Blake Hummer

Collection Method

Likely contains results from a pilot study comparing two proteomic assay platforms.

Time Range

null

Freshness

Last updated 2026-03 18 17:26:18; freshness should be verified.

Geography

null